APA (7th ed.) Citation

Yasmin M. Ahmed, Mohamed A. Abdelgawad, Khaled Shalaby, Mohammed M. Ghoneim, Asmaa M. AboulMagd, Nada S. Abdelwahab, . . . Asmaa M. Othman. (2022). Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway. MDPI AG.

Chicago Style (17th ed.) Citation

Yasmin M. Ahmed, Mohamed A. Abdelgawad, Khaled Shalaby, Mohammed M. Ghoneim, Asmaa M. AboulMagd, Nada S. Abdelwahab, Hossam M. Hassan, and Asmaa M. Othman. Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus Through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway. MDPI AG, 2022.

MLA (9th ed.) Citation

Yasmin M. Ahmed, et al. Pioglitazone Synthetic Analogue Ameliorates Streptozotocin-Induced Diabetes Mellitus Through Modulation of ACE 2/Angiotensin 1-7 via PI3K/AKT/mTOR Signaling Pathway. MDPI AG, 2022.